The number of people with susceptibility test result for rifampicin in Peru
Peru: The number of people with susceptibility test result for rifampicin was 94.02 in 2021. ▲ Rising
Latest (2021)
94.02
Change on year
up 30.6%
World rank
55th
of 146 countries
All-time high
94.02
in 2021
All-time low
71.97
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Peru, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Peru stood at 94.02. That is the highest value across all 5 years on record.
Compared with earlier readings it is up 30.6% on the previous year and up 17.8% over five years.
Peru ranks 55th of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Peru, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 79.81 | — |
| 2018 | 73.45 | -8.0% |
| 2019 | 77.56 | +5.6% |
| 2020 | 71.97 | -7.2% |
| 2021 | 94.02 | +30.6% |
Peru compared with similar countries
- Peru's 94.02 is above the median for upper middle income countries, which is 92.7, 1.0× the median. (45 countries reporting)
- Peru's 94.02 is above the median for Latin America & Caribbean, which is 59.38, 1.6× the median. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 76.94 | 73.45 | 79.81 | 3 |
| 2020s | 82.99 | 71.97 | 94.02 | 2 |
Countries ranked near Peru
- 52 Hong Kong, China 94.83 compare
- 53 United States of America 94.32 compare
- 54 Bahrain 94.12 compare
- 56 Kyrgyzstan 94.01 compare
- 57 Russian Federation 93.52 compare
- 58 Puerto Rico 93.33 compare
More health data for Peru
- Un projection of annual infant deaths, annual growth rate -1.88 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5045 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,235 deaths per 1,000 people (2090)
- Number of infants who die before age 1 782 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate -0.3081 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.038 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.302 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Peru?
- The number of people with susceptibility test result for rifampicin in Peru was 94.02 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Peru?
- The highest recorded value was 94.02 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Peru?
- The lowest recorded value was 71.97 in 2020.
- How does Peru rank for the number of people with susceptibility test result for rifampicin?
- Peru ranks 55th out of 146 countries with data for 2021.
- Where does this Peru data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).